Review: Cannabinoids as Medicinals
Author:
Funder
Office of Research on Women's Health
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Psychology
Link
https://link.springer.com/content/pdf/10.1007/s40429-022-00438-3.pdf
Reference167 articles.
1. • Radwan MM, Chandra S, Gul S, ElSohly MA. Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules. 2021;26:1–29. In a most recent publication, the investigators report that cannabis is a complex plant and contains a mixture of chemical constituents characterized as cannabinoids like THC, CBD and several others but also new THC-like and CBD-like cannabinoids. The plant also contains non-cannabinoid-type constituents that include non-cannabinoid phenols, flavonoids, terpenes, alkaloids, and others.
2. Smith DE. Review of the American Medical Association Council on Scientific Affairs report on medical marijuana. J Psychoactive Drugs. 1998;30:127–36.
3. • Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30:515–27. Here the investigators have provided an excellent overview of the recent pharmacological advances, novel mechanisms of action, and potential therapeutic applications of such non-psychotropic plant-derived cannabinoids, with special emphasis on cannabidiol, the possible applications of which have emerged in a wide range of clinical conditions including inflammation, diabetes, cancer, affective and neurodegenerative diseases; and also discussed the role of delta-9-tetrahydrocannabivarin, a novel CB1 antagonist that may be potentially useful in the treatment of epilepsy and obesity.
4. Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, Gallo L, Capasso F, Orlando P, Di Marzo V. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol. 2012;166:1444–60.
5. Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: Therapeutic use in clinical practice. Int J Mol Sci. 2022;23.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 Mice;2023-12-23
2. Knowledge and Attitudes of Cannabidiol in Croatia among Students, Physicians, and Pharmacists;Pharmacy;2023-12-23
3. Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor;International Journal of Molecular Sciences;2023-12-15
4. Extraction of Active Compounds from Mixtures of Hemp (Cannabis sativa) with Plants of the Zingiberaceae Family;Molecules;2023-11-28
5. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021;BMC Public Health;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3